Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32954927

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Dec 1
First author
Johnston SRD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Dec 1;38(34):3977-3979. doi: 10.1200/JCO.20.02688.
    note
    Source null
    related pmid
    32954928
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2021 Feb;18(2):67-68. doi: 10.1038/s41571-020-00453-1.
    note
    Source null
    related pmid
    33235325
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2021 May 1;39(13):1507-1508. doi: 10.1200/JCO.20.03477.
    note
    Source null
    related pmid
    33630658
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2021 May 1;39(13):1506-1507. doi: 10.1200/JCO.20.03215.
    note
    Source null
    related pmid
    33630669
    relationship
    Comment in
  5. citation
    JCO Oncol Pract. 2022 Jul;18(7):516-519. doi: 10.1200/OP.22.00140.
    note
    Source null
    related pmid
    35377771
    relationship
    Comment in

Authors and identifiers

  1. name
    Johnston SRD
    type
    Author
  2. name
    Harbeck N
    type
    Author
  3. name
    Hegg R
    type
    Author
  4. name
    Toi M
    type
    Author
  5. name
    Martin M
    type
    Author
  6. name
    Shao ZM
    type
    Author
  7. name
    Zhang QY
    type
    Author
  8. name
    Martinez Rodriguez JL
    type
    Author
  9. name
    Campone M
    type
    Author
  10. name
    Hamilton E
    type
    Author
  11. name
    Sohn J
    type
    Author
  12. name
    Guarneri V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Johnston SRD
    type
    Author
  2. name
    Harbeck N
    type
    Author
  3. name
    Hegg R
    type
    Author
  4. name
    Toi M
    type
    Author
  5. name
    Martin M
    type
    Author
  6. name
    Shao ZM
    type
    Author
  7. name
    Zhang QY
    type
    Author
  8. name
    Martinez Rodriguez JL
    type
    Author
  9. name
    Campone M
    type
    Author
  10. name
    Hamilton E
    type
    Author
  11. name
    Sohn J
    type
    Author
  12. name
    Guarneri V
    type
    Author
bibliography ids
  1. nci-bib-0f299b9f3f2334a100413bae
book metadata
content sha256
3993b3c22d595475929de9761b9734851eccef9f9556a53ef1348b8b0a475c7c
document type
citation
dois
  1. 10.1200/JCO.20.02514
electronic publication date
display
2020 Sep 20
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32954927
immutable id
pubmed:32954927@3993b3c22d595475929de9761b9734851eccef9f9556a53ef1348b8b0a475c7c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
34
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3987-3998
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Dec 1;38(34):3977-3979. doi: 10.1200/JCO.20.02688.
    note
    Source null
    related pmid
    32954928
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2021 Feb;18(2):67-68. doi: 10.1038/s41571-020-00453-1.
    note
    Source null
    related pmid
    33235325
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2021 May 1;39(13):1507-1508. doi: 10.1200/JCO.20.03477.
    note
    Source null
    related pmid
    33630658
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2021 May 1;39(13):1506-1507. doi: 10.1200/JCO.20.03215.
    note
    Source null
    related pmid
    33630669
    relationship
    Comment in
  5. citation
    JCO Oncol Pract. 2022 Jul;18(7):516-519. doi: 10.1200/OP.22.00140.
    note
    Source null
    related pmid
    35377771
    relationship
    Comment in
outcomes validated
false
pmid
32954927
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
6510ab172b33bb90f36a60f9c3c70055c880e7747fac55b722ab95228cd03ef5
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Dec 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32954927/
title
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).

Preserved source evidence · Not medical advice